SWOG clinical trial number
SWOG-8811
Phase II Trial of 5-Fluorouracil and High Dose Folinic Acid as First or Second Line Therapy for Advanced Breast Cancer
Closed
Phase
Accrual
77%
Published
Abbreviated Title
Phase II Trial of 5-Fluorouracil and High Dose Folinic Acid as First or Second Line Therapy for Advanced Breast Cancer
Activated
09/01/1988
Closed
11/15/1990
Publication Information Expand/Collapse
1994
Phase II trial of 5-fluorouracil and high-dose folinic acid as first or second-line therapy for advanced breast cancer.
1991
Treatment of advanced breast cancer with 5-FU and high dose folinic acid.